[Nifedipine in the treatment of arterial hypertension in patients with the neuroendocrine-metabolic form of the hypothalamic syndrome].
The authors submit results of treatment of 30 patients presenting with neuroendocrine-metabolic form of hypothalamic syndrome with a 3-months course administration of nifedipine on a 30-mg daily schedule. Before the treatment, the patients had persistent arterial hypertension and abnormal values for central hemodynamics presenting as hypokinetic syndrome. After the treatment with corinfar, the patients fared significantly better, with the arterial pressure and index of the general peripheral vascular resistance getting down. Values for minute volume, stroke volume, cardiac index tended towards normalization.
Oleĭnik
V A
VA
Zubkova
S T
ST
Kamenetskaia
M S
MS
Terekhova
G N
GN
D000328:Adult; D003131:Combined Modality Therapy; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D007027:Hypothalamic Diseases / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D009543:Nifedipine / Q000008:administration & dosage*; D012074:Remission Induction; D013577:Syndrome
D009543:Nifedipine